Aileron Therapeutics
ALRN
$3.82
Share price
-8.17%
Change (1 day)
180.88%
Change (1 year)
Categories
Aileron Therapeutics (ALRN) - Cash on Hand
Cash on Hand as of December 2023 : $17.31 M
According to Aileron Therapeutics
's latest financial reports the company has $17.31 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Aileron Therapeutics - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $21.24 M | -53.75% |
| 2021-12-31 | $45.93 M | 232.73% |
| 2020-12-31 | $13.8 M | -24.47% |
| 2019-12-31 | $18.27 M | -11.68% |
| 2018-12-31 | $20.69 M | -59.22% |
| 2017-12-31 | $50.75 M | 145% |
| 2016-12-31 | $20.71 M | 449.76% |
| 2015-12-31 | $3.76 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 1,102.49% | 🇺🇸 USA |